Protein-based antigen presentation platforms for nanoparticle vaccines
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases such as COVID-19, malaria, and AIDS there is a clear urgency for more effective next-generation vaccines. One approach to improve the immunogenicity of vaccines is the use of nanoparticle platforms that present a repetitive array of antigen on its surface. This technology has been shown to improve antigen presenting cell uptake, lymph node trafficking, and B-cell activation through increased avidity and particle size. With a focus on design, we summarize natural platforms, methods of antigen attachment, and advancements in generating self-assembly that have led to new engineered platforms. We further examine critical parameters that will direct the usage and development of more effective platforms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,061
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
T Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 737
Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy
King, N. P., Sheffler, W., Sawaya, M. R., Vollmar, B. S., Sumida, J. P., André, I., Gonen, T., Yeates, T. O., & Baker, D. (2012) · Science · doi:10.1126/science.1219364 · Cited by 650
Bache, E. B., Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Kabwende, A. L., Adégnika, A. A., Mordmüller, B. G., Kremsner, P. G., Loembé, M. M., et al. (2015) · The Lancet · doi:10.15496/publikation-6508 · Cited by 642
Accurate design of megadalton-scale two-component icosahedral protein complexes
Bale, J. B., Gonen, S., Liu, Y., Sheffler, W., Ellis, D., Thomas, C., Cascio, D., Yeates, T. O., Gonen, T., King, N. P., et al. (2016) · Science · doi:10.1126/science.aaf8818 · Cited by 564
Proof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555
Accurate design of co-assembling multi-component protein nanomaterials
King, N. P., Bale, J. B., Sheffler, W., McNamara, D. E., Gonen, S., Gonen, T., Yeates, T. O., & Baker, D. (2014) · Nature · doi:10.1038/nature13404 · Cited by 551
Protein Assembly: Versatile Approaches to Construct Highly Ordered Nanostructures
Luo, Q., Hou, C., Bai, Y., Wang, R., & Liu, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00228 · Cited by 542
Walls, A. C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O’Connor, M. A., Chen, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.043 · Cited by 532
Nanoparticle Vaccines Against Infectious Diseases
Pati, R., Shevtsov, M., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 514
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Marcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W., Snijder, J., Hodge, E., Benhaim, M., Ravichandran, R., Carter, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 448
Design of a hyperstable 60-subunit protein icosahedron
Hsia, Y., Bale, J. B., Gonen, S., Shi, D., Sheffler, W., Fong, K. K., Nattermann, U., Xu, C., Huang, P.-S., Ravichandran, R., et al. (2016) · Nature · doi:10.1038/nature18010 · Cited by 445
Nanohedra: Using symmetry to design self assembling protein cages, layers, crystals, and filaments
Padilla, J. E., Colovos, C., & Yeates, T. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614998 · Cited by 441
Role of nanoscale antigen organization on B-cell activation probed using DNA origami
Veneziano, R., Moyer, T. J., Stone, M. B., Wamhoff, E.-C., Read, B. J., Mukherjee, S., Shepherd, T. R., Das, J., Schief, W. R., Irvine, D. J., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0719-0 · Cited by 429
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Brune, K. D., Leneghan, D. B., Brian, I. J., Ishizuka, A. S., Bachmann, M. F., Draper, S. J., Biswas, S., & Howarth, M. (2016) · Scientific Reports · doi:10.1038/srep19234 · Cited by 412
Bioengineering virus‐like particles as vaccines
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25159 · Cited by 355
Self-assembling protein nanoparticles in the design of vaccines
López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.11.001 · Cited by 353
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Bangaru, S., Ozorowski, G., Turner, H. L., Antanasijevic, A., Huang, D., Wang, X., Torres, J. L., Diedrich, J. K., Tian, J.-H., Portnoff, A. D., et al. (2020) · Science · doi:10.1126/science.abe1502 · Cited by 346
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
Hempstead, P. D., Yewdall, S. J., Fernie, A. R., Lawson, D. M., Artymiuk, P. J., Rice, D. W., Ford, G. C., & Harrison, P. M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0970 · Cited by 318
On Natural and Artificial Vaccinations
Zinkernagel, R. M. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141045 · Cited by 309
Structure of a designed protein cage that self-assembles into a highly porous cube
Lai, Y.-T., Reading, E., Hura, G. L., Tsai, K.-L., Laganowsky, A., Asturias, F. J., Tainer, J. A., Robinson, C. V., & Yeates, T. O. (2014) · Nature Chemistry · doi:10.1038/nchem.2107 · Cited by 297
Understanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 293
Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination
Bruun, T. U. J., Andersson, A.-M. C., Draper, S. J., & Howarth, M. (2018) · ACS Nano · doi:10.1021/acsnano.8b02805 · Cited by 281
Structure of a 16-nm Cage Designed by Using Protein Oligomers
Lai, Y.-T., Cascio, D., & Yeates, T. O. (2012) · Science · doi:10.1126/science.1219351 · Cited by 278
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
Kato, Y., Abbott, R. K., Freeman, B. L., Haupt, S., Groschel, B., Silva, M., Menis, S., Irvine, D. J., Schief, W. R., & Crotty, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.001 · Cited by 269
Prevention of Hepatitis B with the Hepatitis B Vaccine
Poland, G. A., & Jacobson, R. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp041507 · Cited by 268
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Collins, K. A., Snaith, R., Cottingham, M. G., Gilbert, S. C., & Hill, A. V. S. (2017) · Scientific Reports · doi:10.1038/srep46621 · Cited by 253
From the circumsporozoite protein to the RTS,S/AS candidate vaccine
Cohen, J., Nussenzweig, V., Vekemans, J., & Leach, A. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9677 · Cited by 247
Nanoparticle Delivery Systems in Cancer Vaccines
Krishnamachari, Y., Geary, S. M., Lemke, C. D., & Salem, A. K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0241-4 · Cited by 219
Zhang, X., Meining, W., Fischer, M., Bacher, A., & Ladenstein, R. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4435 · Cited by 217
Haemophilus influenzae type b conjugate vaccines
Kelly, D. F., Moxon, E. R., & Pollard, A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01971.x · Cited by 214
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
Tissot, A. C., Renhofa, R., Schmitz, N., Cielens, I., Meijerink, E., Ose, V., Jennings, G. T., Saudan, P., Pumpens, P., & Bachmann, M. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009809 · Cited by 206
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Thrane, S., Janitzek, C. M., Matondo, S., Resende, M., Gustavsson, T., de Jongh, W. A., Clemmensen, S., Roeffen, W., van de Vegte‑Bolmer, M., van Gemert, G. J., et al. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0181-1 · Cited by 203
Zhang, Y.-N., Lazarovits, J., Poon, W., Ouyang, B., Nguyen, L. N. M., Kingston, B. R., & Chan, W. C. W. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02834 · Cited by 198
Brouwer, P. J. M., Antanasijevic, A., Berndsen, Z., Yasmeen, A., Fiala, B., Bijl, T. P. L., Bontjer, I., Bale, J. B., Sheffler, W., Allen, J. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12080-1 · Cited by 184
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
He, L., de Val, N., Morris, C. D., Vora, N., Thinnes, T. C., Kong, L., Azadnia, P., Sok, D., Zhou, B., Burton, D. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms12041 · Cited by 182
Izard, T., Ævarsson, A., Allen, M. D., Westphal, A. H., Perham, R. N., de Kok, A., & Hol, W. G. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1240 · Cited by 180
Kaiser, C. R., Flenniken, M. L., Gillitzer, E., Harmsen, A. L., Harmsen, A. G., Jutila, M. A., Douglas, T., & Young, M. (2007) · PubMed · Cited by 178
Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
Jia, J., Zhang, Y., Xin, Y., Jiang, C., Yan, B., & Zhai, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00404 · Cited by 174
Brune, K. D., & Howarth, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01432 · Cited by 161
Kwon, Y. J., Standley, S. M., Goh, S. L., & Fréchet, J. M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.027 · Cited by 149
Responsiveness of B cells is regulated by the hinge region of IgD
Übelhart, R., Hug, E., Bach, M. P., Wossning, T., Minden, M. D.-V., Horn, A. H. C., Tsiantoulas, D., Kometani, K., Kurosaki, T., Binder, C. J., et al. (2015) · Nature Immunology · doi:10.1038/ni.3141 · Cited by 146
Lu, Y., Chan, W., Ko, B. Y., VanLang, C. C., & Swartz, J. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510533112 · Cited by 142
Zhang, B., Chao, C. W., Tsybovsky, Y., Abiona, O. M., Hutchinson, G. B., Moliva, J. I., Olia, A. S., Pegu, A., Phung, E., Stewart-Jones, G. B. E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74949-2 · Cited by 141
Shaping humoral immunity to vaccines through antigen-displaying nanoparticles
Irvine, D. J., & Read, B. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.007 · Cited by 132
Virus-like particle display of HER2 induces potent anti-cancer responses
Palladini, A., Thrane, S., Janitzek, C. M., Pihl, J., Clemmensen, S. B., de Jongh, W. A., Clausen, T. M., Nicoletti, G., Landuzzi, L., Penichet, M. L., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1408749 · Cited by 129
Kaba, S. A., McCoy, M. E., Doll, T. A. P. F., Brando, C., Guo, Q., Dasgupta, D., Yang, Y., Mittelholzer, C., Spaccapelo, R., Crisanti, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048304 · Cited by 120
Sagara, I., Healy, S. A., Assadou, M. H., Gabriel, E. E., Koné, M., Sissoko, K., Tembiné, I., Guindo, M. A., Doucoure, M., Niaré, K., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30344-x · Cited by 119
Bioengineering Strategies for Protein-Based Nanoparticles
Diaz, D., Care, A., & Sunna, A. (2018) · Genes · doi:10.3390/genes9070370 · Cited by 115
Geometric Principles for Designing Highly Symmetric Self-Assembling Protein Nanomaterials
Yeates, T. O. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-033928 · Cited by 112
Surface hydrophobicity of microparticles modulates adjuvanticity
Liu, Y., Yin, Y., Wang, L., Zhang, W., Chen, X., Yang, X., Xu, J., & Ma, G. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20383b · Cited by 107
Shimp, R. L., Rowe, C. G., Reiter, K., Chen, B., Nguyen, V., Aebig, J. A., Rausch, K. M., Kumar, K., Wu, Y., Jin, A. J., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.034 · Cited by 106
Brune, K. D., Buldun, C. M., Li, Y., Taylor, I. J., Brod, F., Biswas, S., & Howarth, M. R. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00174 · Cited by 106
de Vlieger, J. S. B., Crommelin, D. J. A., Tyner, K., Drummond, D. C., Jiang, W., McNeil, S. E., Neervannan, S., Crist, R. M., & Shah, V. P. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0329-7 · Cited by 100
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Shin, H., Park, S. D., Yim, Y., Kim, J., Choi, C., Won, C., & Min, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800065 · Cited by 100
Li, Y., Leneghan, D. B., Miura, K., Nikolaeva, D., Brian, I. J., Dicks, M. D. J., Fyfe, A. J., Zakutansky, S. E., de Cassan, S., Long, C. A., et al. (2016) · Scientific Reports · doi:10.1038/srep18848 · Cited by 98
Flexible, symmetry-directed approach to assembling protein cages
Sciore, A., Su, M., Koldewey, P., Eschweiler, J. D., Diffley, K. A., Linhares, B. M., Ruotolo, B. T., Bardwell, J. C. A., Skiniotis, G., & Marsh, E. N. G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606013113 · Cited by 96
The effect of interactions on the cellular uptake of nanoparticles
Chaudhuri, A., Battaglia, G., & Golestanian, R. (2011) · Physical Biology · doi:10.1088/1478-3975/8/4/046002 · Cited by 93
HIV-1 vaccine design through minimizing envelope metastability
He, L., Kumar, S., Allen, J. D., Huang, D., Lin, X., Mann, C. J., Saye-Francisco, K. L., Copps, J., Sarkar, A., Blizard, G. S., et al. (2018) · Science Advances · doi:10.1126/sciadv.aau6769 · Cited by 93
Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens
Georgiev, I. S., Joyce, M. G., Chen, R. E., Leung, K., McKee, K., Druz, A., Galen, J. G. V., Kanekiyo, M., Tsybovsky, Y., Yang, E. S., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00192 · Cited by 91
Near-atomic cryo-EM imaging of a small protein displayed on a designed scaffolding system
Liu, Y., Gonen, S., Gonen, T., & Yeates, T. O. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718825115 · Cited by 89
Wang, D., Harmon, A. F., Jin, J., Francis, D. H., Christopher‐Hennings, J., Nelson, E. A., Montelaro, R. C., & Li, F. (2010) · Journal of Virology · doi:10.1128/jvi.02306-09 · Cited by 83
The effect of interactions on the cellular uptake of nanoparticles
Chaudhuri, A., Battaglia, G., & Golestanian, R. (2011) · UCL Discovery (University College London) · Cited by 80
Structure of AP205 Coat Protein Reveals Circular Permutation in ssRNA Bacteriophages
Sisovs, M., Rumnieks, J., Diebolder, C. A., Jaudzems, K., Andreas, L. B., Stanek, J., Kazāks, A., Koteloviča, S., Akopjana, I., Pintacuda, G., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.025 · Cited by 76
Leneghan, D. B., Miura, K., Taylor, I. J., Li, Y., Jin, J., Brune, K. D., Bachmann, M. F., Howarth, M. R., Long, C. A., & Biswas, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-03798-3 · Cited by 75
Cristie‐David, A. S., Chen, J., Nowak, D. B., Bondy, A. L., Sun, K., Park, S. I., Holl, M. M. B., Su, M., & Marsh, E. N. G. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13604 · Cited by 65
Liu, Y. V., Massare, M. J., Pearce, M. B., Sun, X., Belser, J. A., Maines, T. R., Creager, H. M., Glenn, G. M., Pushko, P., Smith, G., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.009 · Cited by 60
RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials
van den Berg, M., Ogutu, B. R., Sewankambo, N. K., Biller‐Andorno, N., & Tanner, M. (2019) · Trials · doi:10.1186/s13063-019-3391-7 · Cited by 57
Kobayashi, N., & Arai, R. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.01.001 · Cited by 56
Buffin, S., Peubez, I., Barrière, F., Nicolaï, M., Tapia, T. M., Dhir, V., Forma, E., Sève, N., & Legastelois, I. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.057 · Cited by 51
Beyond icosahedral symmetry in packings of proteins in spherical shells
Mosayebi, M., Shoemark, D. K., Fletcher, J. M., Sessions, R. B., Linden, N., Woolfson, D. N., & Liverpool, T. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706825114 · Cited by 46
Deo, V. K., Kato, T., & Park, E. Y. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500860x · Cited by 45
Cannon, K. A., Nguyen, V. N., Morgan, C., & Yeates, T. O. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00392 · Cited by 43
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
McCraw, D. M., Gallagher, J. R., Torian, U., Myers, M. L., Conlon, M. T., Gulati, N. M., & Harris, A. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-28700-7 · Cited by 37
Particle-based platforms for malaria vaccines
Wu, Y., Narum, D. L., Fleury, S., Jennings, G. T., & Yadava, A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.097 · Cited by 32
Characterization of a highly flexible self‐assembling protein system designed to form nanocages
Patterson, D. P., Su, M., Franzmann, T. M., Sciore, A., Skiniotis, G., & Marsh, E. N. G. (2013) · Protein Science · doi:10.1002/pro.2405 · Cited by 30
Carter, D. C., Wright, B., Jerome, W. G., Rose, J. P., & Wilson, E. J. (2020) · Journal of Nanomaterials · doi:10.1155/2020/4297937 · Cited by 27
Recent Advances in Particulate Adjuvants for Cancer Vaccination
Song, C., Li, F., Wang, S., Wang, J., Wei, W., & Ma, G. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900115 · Cited by 24
Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2Preprint
Yao, D., Lao, F., Zhang, Z., Liu, Y., Cheng, J., Ding, F., Wang, X., Xi, L., Wang, C., Yan, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.25.115618 · Cited by 9
Lainšček, D., Fink, T., Forstnerič, V., Hafner‐Bratkovič, I., Orehek, S., Strmšek, Ž., Manček‐Keber, M., Pečan, P., Esih, H., Malenšek, Š., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.28.244269 · Cited by 9
Cited by
Machine learning for functional protein design
Notin, P., Rollins, N., Gal, Y., Sander, C., & Marks, D. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02127-0 · Cited by 270
Yang, J., Luly, K. M., & Green, J. J. (2023) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1853 · Cited by 40
Metadata
- Authors
- Nguyen, B., & Tolia, N. H.
- Venue
- npj Vaccines
- Published
- 2021-05-13
- Volume
- 6
- Issue
- 1
- Pages
- 70-70
- ISSN
- 2059-0105 (ISSN-L)
- OpenAlex
- W3160834656
- Cited by
- 271
- References
- 90
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.